{'fraction_non_alphanumeric': 0.022988505747126436, 'fraction_numerical': 0.0038314176245210726, 'mean_word_length': 5.973333333333334, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Transient elastography for monitoring the fibrosis of non‐alcoholic fatty liver disease for 4 years

There have been some reports on the use of paired biopsies for monitoring disease progression in non‐alcoholic fatty liver disease (NAFLD) patients. Recently, transient elastography has been developed as a non‐invasive method for predicting the severity of liver fibrosis. We investigated 4‐year disease progression in NAFLD patients by evaluating liver stiffness measurements (LSM) obtained using transient elastography.